biopharmaceutics


Also found in: Dictionary, Encyclopedia.

bi·o·phar·ma·ceu·tics

(bī'ō-far'mă-sū'tiks),
The study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action, including coconstituents and mode of manufacture.

biopharmaceutics

(bī′ō-fär′mə-so͞o′tĭks)
n.
(used with a sing. verb) The study of the properties of pharmaceutical preparations and their effects after administration.

biopharmaceutics

[-fär′məso̅o̅′tiks]
the study of the chemical and physical properties of drugs, their components, and their activities in living organisms. See also pharmacokinetics and pharmacodynamics.

bi·o·phar·ma·ceu·tics

(bī'ō-fahr'mă-sū'tiks)
The study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action.

bi·o·phar·ma·ceu·tics

(bī'ō-fahr'mă-sū'tiks)
Study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action.
References in periodicals archive ?
Benita, "Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs," European Journal of Pharmaceutics and Biopharmaceutics, vol.
Predicting drug disposition via application of BCS: trans-port/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system.
Journal of Biopharmaceutics & Biotechnology" is targeted to professionals in pharmaceutical sciences, medicine, medicinal chemistry, biotechnology, bioinformatics, biochemical engineering and the biomedical sciences.
Bernard Cabana, ActivBiotics' VP of Preclinical and Clinical Pharmacology and former founder and Director of the FDA's Division of Biopharmaceutics, stated, "The pharmacokinetic and tissue distribution of rifalazil is best described by a two-compartment open-model.
Sectors covered include human and animal healthcare (biomedical developments, functional genomics and gene analyses, proteomics, diagnosis and diagnostics, molecular cellular monitoring, medical microbiology), biopharmaceutics (novel therapeutics, vaccines, gene therapy), foods and beverages (novel foods, nutriceuticals, functional foods), agriculture and horticulture (plant and animal breeding, plant resistance and tolerance, biopesticides, bio-insecticides), and environmental protection and control (bioremediation and biodegradation, biomonitoring and control, air pollution treatment, ecological risks, hazards assessment).
The Biopharmaceutics Section, headed by Iain McGilveray, FCIC, is involved in a number of clinical projects based on bioanalytical chemistry; specifically development and application of methods for measurement of drugs and their metabolites in tissue, mainly in blood plasma.
and for the FDA office of Clinical Pharmacology and Biopharmaceutics as a reviewer of more than 50 NDA and sNDA submissions and more than 200 IND submissions.
Spiro Spireas, the inventor and author of more than 80 international and domestic patents and 200 scientific papers, books and other publications in the fields of industrial pharmacy, biopharmaceutics, pharmacokinetics, pharmaceutical technology and analytical chemistry, founded Sigmapharm in 2005 and is the company's chairman and chief executive officer.
American Association of Pharmaceutical Scientists (AAPS) members primarily come from a pharmaceutics, biopharmaceutics, or pharmacy field of study.
His industry experience includes but is not limited to previous positions as president of GloboMax Americas and director of Biopharmaceutics and Pharmacokinetics at Schering-Plough Research, Miami.